Format
Sort by
Items per page

Send to

Choose Destination

Best matches for schizophrenia AND substance abuse problem:

Violence in schizophrenia and bipolar disorder. Volavka J et al. Psychiatr Danub. (2013)

The problem of substance abuse in people with schizophrenia. DeLisi LE et al. Curr Opin Psychiatry. (2015)

Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study. Wobrock T et al. Schizophr Res. (2013)

Search results

Items: 1 to 20 of 6217

1.

Problem and Pathological Gambling in Schizophrenia: Exploring Links with Substance Use and Impulsivity.

Fortgang RG, Hoff RA, Potenza MN.

J Gambl Stud. 2018 Feb 16. doi: 10.1007/s10899-018-9757-z. [Epub ahead of print]

PMID:
29453588
2.

Large animals as potential models of human mental and behavioral disorders.

Danek M, Danek J, Araszkiewicz A.

Psychiatr Pol. 2017 Dec 30;51(6):1009-1027. doi: 10.12740/PP/74304. Epub 2017 Dec 30. Review. English, Polish.

3.

Acute Crisis Care for Patients with Mental Health Crises: Initial Assessment of an Innovative Prehospital Alternative Destination Program in North Carolina.

Creed JO, Cyr JM, Owino H, Box SE, Ives-Rublee M, Sheitman BB, Steiner BD, Williams JG, Bachman MW, Cabanas JG, Myers JB, Glickman SW.

Prehosp Emerg Care. 2018 Feb 7:1-10. doi: 10.1080/10903127.2018.1428840. [Epub ahead of print]

PMID:
29412043
4.

Childhood trauma in schizophrenia spectrum disorders as compared to substance abuse disorders.

Mørkved N, Winje D, Dovran A, Arefjord K, Johnsen E, Kroken RA, Anda-Ågotnes LG, Thimm JC, Sinkeviciute I, Rettenbacher M, Løberg EM.

Psychiatry Res. 2018 Mar;261:481-487. doi: 10.1016/j.psychres.2018.01.011. Epub 2018 Jan 10.

PMID:
29360053
5.

Validation of CRAFFT for Use in Youth Correctional Institutions in Lagos, Nigeria.

Ola B, Atilola O.

J Am Acad Psychiatry Law. 2017 Dec;45(4):439-446.

PMID:
29282234
6.

European Court of Human Rights.

Dute J.

Eur J Health Law. 2016 Dec;23(5):525-37. No abstract available.

PMID:
29210250
7.

Analysis of the Prevalence of Mental Disorders in Psoriasis: The Relevance of Psychiatric Assessment in Dermatology.

Ferreira BR, Pio-Abreu JL, Reis JP, Figueiredo A.

Psychiatr Danub. 2017 Dec;29(4):401-406. doi: 10.24869/psyd.2017.401.

8.

Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis.

O'Brien M, Burke T, Heverin M, Vajda A, McLaughlin R, Gibbons J, Byrne S, Pinto-Grau M, Elamin M, Pender N, Hardiman O.

JAMA Neurol. 2017 Dec 1;74(12):1425-1430. doi: 10.1001/jamaneurol.2017.2699.

PMID:
29049464
9.

Risk characterization of hospitalizations for mental illness and/or behavioral disorders with concurrent heat-related illness.

Schmeltz MT, Gamble JL.

PLoS One. 2017 Oct 16;12(10):e0186509. doi: 10.1371/journal.pone.0186509. eCollection 2017.

10.

Involvement of posterior cingulate cortex in ketamine-induced psychosis relevant behaviors in rats.

Ma J, Leung LS.

Behav Brain Res. 2018 Feb 15;338:17-27. doi: 10.1016/j.bbr.2017.09.051. Epub 2017 Oct 7.

PMID:
28993219
11.

Dissociation in Psychiatric Disorders: A Meta-Analysis of Studies Using the Dissociative Experiences Scale.

Lyssenko L, Schmahl C, Bockhacker L, Vonderlin R, Bohus M, Kleindienst N.

Am J Psychiatry. 2018 Jan 1;175(1):37-46. doi: 10.1176/appi.ajp.2017.17010025. Epub 2017 Sep 26.

PMID:
28946763
12.

Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotics in schizophrenia patients with substance-related disorders using Medicaid benefits.

Joshi K, Lafeuille MH, Kamstra R, Tiggelaar S, Lefebvre P, Kim E, Yue Y, Tandon N.

J Comp Eff Res. 2017 Aug 15. doi: 10.2217/cer-2017-0043. [Epub ahead of print]

13.

Clinical Epidemiology of Single Versus Multiple Substance Use Disorders: Polysubstance Use Disorder.

Bhalla IP, Stefanovics EA, Rosenheck RA.

Med Care. 2017 Sep;55 Suppl 9 Suppl 2:S24-S32. doi: 10.1097/MLR.0000000000000731.

PMID:
28806363
14.

No Perfect Choice.

Dossett EC, Wusirika L, Burt V.

JAMA. 2017 Jul 4;318(1):29-30. doi: 10.1001/jama.2017.5523. No abstract available. Erratum in: JAMA. 2017 Aug 15;318(7):669.

PMID:
28672322
15.

Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans With Schizophrenia and Comorbid Substance Abuse.

Lefebvre P, Muser E, Joshi K, DerSarkissian M, Bhak RH, Duh MS, Shiner B, Young-Xu Y.

Clin Ther. 2017 Jul;39(7):1380-1395.e4. doi: 10.1016/j.clinthera.2017.05.356. Epub 2017 Jun 20.

16.

Does Half-Life Matter After Antipsychotic Discontinuation? A Relapse Comparison in Schizophrenia With 3 Different Formulations of Paliperidone.

Weiden PJ, Kim E, Bermak J, Turkoz I, Gopal S, Berwaerts J.

J Clin Psychiatry. 2017 Jul;78(7):e813-e820. doi: 10.4088/JCP.16m11308.

17.

Is there a specific psychiatric background or personality profile in functional dystonia?

Tomić A, Petrović I, Pešić D, Vončina MM, Svetel M, Mišković ND, Potrebić A, Toševski DL, Kostić VS.

J Psychosom Res. 2017 Jun;97:58-62. doi: 10.1016/j.jpsychores.2017.04.004. Epub 2017 Apr 12.

PMID:
28606500
18.

Effects of childhood and adolescence physical activity patterns on psychosis risk-a general population cohort study.

Sormunen E, Saarinen MM, Salokangas RKR, Telama R, Hutri-Kähönen N, Tammelin T, Viikari J, Raitakari O, Hietala J.

NPJ Schizophr. 2017 Jan 13;3:5. doi: 10.1038/s41537-016-0007-z. eCollection 2017.

19.

Prognosis at 6 and 12months after self-attempted hanging.

Gantois G, Parmentier-Decrucq E, Duburcq T, Favory R, Mathieu D, Poissy J.

Am J Emerg Med. 2017 Nov;35(11):1672-1676. doi: 10.1016/j.ajem.2017.05.037. Epub 2017 May 23.

PMID:
28551089
20.

Clinical News.

Buckley PF.

Clin Schizophr Relat Psychoses. Spring 2017;11(1):26-28. doi: 10.3371/1935-1232-11.1.26. No abstract available.

PMID:
28548575

Supplemental Content

Loading ...
Support Center